Richtlijnen

Klik HIER voor de richtlijn 'Myelodysplastisch syndroom' van het European LeukemiaNet.

Klik HIER voor de richtlijn 'Myelodysplastisch syndroom' van het EU-MDS consortium.

Literatuur

  1. Döhner H. et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN - Blood 2022 - 140 (12): 1345-1377
  2. Arber D.A. et al. International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical and genomic data - Arber et al. - Blood 2022 - 140 (11): 1200-1228
  3. Khoury et al. The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic dendritic neoplasms - Leukemia 2022 - 36: 1703-1719
  4. Greenberg  PL et al. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120: 2454-2465
  5. Greenberg PL et al. International prognostic scoring system for myelodysplastic syndromes. Blood 1997; 89: 2079-2088
  6. Malcovati L et al. Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet. Blood 2013 122:2943-2964
  7. Cheson B.D. et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood 2006, volume 108, number 2
  8. Bernard E. et al. Molecular international prognostic scoring system for myelodysplastic syndromes. NEJM Evid 2022;1(7)
  9. Cremers E. et al. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes. Haematologica 2017; 102(2)320-326
  10. Ogata et al. Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study. Haematologica 2009; 94:1066-1074
  11. Westers et al. Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia 2012; 26:170-1741
  12. Van de Loosdrecht et al. Cutting edge flow cytometry in myelo­dysplastic syndromes. J Natl Compr Canc Netw. 2013; 11:892-902
  13. Westers et al. Immunophenotypic analysis of erythroid dysplasia in myelo­dysplastic syndromes. A report from the IMDS Flow working group. Haematologica. 2017; 102:308-319

 

Ga terug naar de MDS homepage of lees meer over MDS:

Ga terug naar de algemene homepage Behandelprotocollen